Prebiotics Activity of Laminaran Derived From Sargassum crassifolium

Anies Chamidah, Hardoko Hardoko, Asep Awaludin Prihanto


The objectives of this study were to evaluate the prebiotic activity based on the change in cell biomass of the probiotic strain after 24-h growth in the presence of Laminaran from Sargassum crassifolium with the methods of laminaran acid extract (LAE) and laminaran modified extract (LME), inulin, or glucose-relative against the change in cell biomass of Escherichia coli FNCC 0091 grown under the same condition. Prebiotic activity was calculated for L. plantarum FNCC 0051 and Bifidobacterium longum FNCC 1081. The results showed that the increasing cell number of L. plantarum was higher in both substrates LAE and LME (0,58 and 2,03log cycle), whereas that of B. longum was lower. The higher prebiotic activity score obtained for L. plantarum and B. longum grown on LME were positive (0,26 and 0,96 log cycle), whereas the lowest score was for L. plantarum and B. longum grown on LAE, which were negative (-0,35 and -0,31 log cycle), but the higher prebiotic activity score was obtained for inulin (4,08 and 4,78 log cycle). It could be concluded that Laminaran Modified Extract (LME) has potential as prebiotic source, but its potential was lower than inulin.


Laminaran Acid Extract; Laminaran Modified Extract; prebiotic activity score

Full Text:



Flint, H.J., S.H. Duncan, K.P. Scott, P. Louis. 2007. Interactions and competition within the microbial community of the human colon: links between diet and health. Environ. Microbiol. 9:1101-1111.

Gibson, G.R., and Roberfroid, M.B. 1995. Dietary modulation of the human colonic microbiota : Introducing the concept of prebiotics. J. Nutr. 125: 1401-1412.

Hartemink, R., Van Laere, KMJ., and Rombouts, FM. 1997. Growth of enterobacteria on fructo-oligosaccharides. J. Appl. Microbiol. 83: 367–374.

Huebner, J., Wehling, R.L. and Hutkins.R.W. 2007. Functional activity of commercial prebiotics. Int Dairy J. 17: 770-775.

Lambertus, A.M., Van Den Broek and Voragen, A.G.J. 2008.Bifidobacterium Glycoside Hydrolases and (Potential) Prebiotics. Innov Food Sci Emerg Technol. 9: 401-407.

Mohsen, A.M.S., Mohamed, S.F., Ali, F.M. and El-Sayed, O.H. 2007. Chemical Structure and Antiviral Activity of Water-soluble Sulfated Polysaccharides from Surgassum latifolium. J Appl Sci Res. 3(10): 1178-1185.

Moore, K.E. 2011.Biological Analysis of Prebiotics in Various Processed Food Matrices. Presented to the Faculty of The Graduate College at the University of Nebraska In Partial Fulfillment of Requirements . For the Degree of Master of Science. Major: Food Science and Technology. Lincoln, Nebraska.

Morrison,D.J., Mackay,W.G., Edwards, C.A., Preston, T.,Dodson, B. and Weaver, L.T. 2006. Butyrate production from oligofructose fermentation by the human faecal flora: what is the contribution of extracellular acetate and lactate? Br J Nutr. 96, 570–577.

O’ Sullivan, L., Murphy, B., McLoughlin, P., Duggan, P., Lawlor, PG., Hughes, H. and Gardiner, G.E. 2010. Prebiotics from marine macroalgae for human and animal health applications. Mar. Drugs . 8: 2038–2064.

Roberfroid, M.B. 2007 . Inulin-Type Fructans: Functional Food Ingredients. J. Nutr. 137: 2493S-2502S.

Rossi, M., Corradini, C., Amaretti, A., Nicolini, M., Pompei, A., Zanoni, S. dan Matteuzzi, D. 2005. Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Appl. Environ Microbiol. 6150–6158

Salyers, A.A., Palmer, J.K. and Wilkins, T.D. 1977. Laminarinase (-Glucanase) Activity in Bacteroides from the Human Colon. Appl Environ Microbiol. 1118-1124.

Steer, T., H. Carpenter, K. Tuohy, and G. R. Gibson. 2000. Perspectives on the role of the human gut microbiota in health and disease and its modulation by pro- and prebiotics. Nutr. Res. Rev. 13:229–254.

Venter, C.S. 2007. Prebiotics: an update. J. Fam. Ecol. Consum. Sci. 35:17-25.

Yvin, J.C., LeVasseur, F. and Hud’Homme, F. 1999. Use of laminarin and oligosaccharides derived therefrom in cosmetics and for preparing a skin treatment drug. US Patent. 59 80 916.



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.